{"success":true,"data":{"pressRelease":{"id":"167328","rtpr_id":"nPnb2dml4a-20261013","ticker":"PAIN","exchange":"","all_tickers":["PAIN"],"title":"Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.","author":"PR Newswire","published_at":"2026-10-13T11:30:00.089Z","article_body":"Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.\nPR Newswire\n\nMEQUON, Wis., Oct. 13, 2026\n\nInvestment advances collaboration on peptide-based products for women's\nwellness\n\nMEQUON, Wis., Oct. 13, 2026 /PRNewswire/ -- Vector Science and Therapeutics\nCorp. (TSXV: PAIN) (\"Vector\" or the \"Company\") today announced that it has\nentered into a strategic relationship with Whoopi Wellness, Inc. (\"Whoopi\nWellness\"), a subsidiary of WhoopFam LLC and co-founded by Whoopi Goldberg.\n\nVector has made an investment in Whoopi Wellness through a Simple Agreement\nfor Future Equity (SAFE). The companies plan to work together on peptide-based\nproducts for women's wellness using peptides formulated and manufactured by\nVector. Vector only uses peptides that have been tested using validated\nanalytical testing to ensure purity, potency, endotoxin levels and sterility.\nWhoopi Wellness is committed to high-quality, safe, rigorously tested peptides\nin its products.\n\nStrategic Rationale\n\nVector believes this relationship brings together Vector's peptide\nmanufacturing expertise and Whoopi Wellness's consumer brand to develop\nproducts for women's wellness.\n\nVector's proprietary delivery technology is central to the relationship. The\nCompany's intellectual property portfolio includes 15 pending patent\napplications covering multi-route peptide and biologic delivery, lyophilized\npeptide formulations with point-of-care reconstitution, and advanced\ntransdermal delivery. Peptides are typically unstable once in liquid form,\nwhich has limited how they can be used in consumer products. Vector's\nexpertise is in the novel delivery of molecules in multiple forms while\npreserving the integrity of the molecule. In the Whoopi Wellness products,\nVector will be using its IP and formulation knowledge to deliver products with\npeptides that retain their potency and that are shelf stable in liquid and gel\nformats. Vector believes this capability positions the companies to explore\npeptide-based products in formats suited to Whoopi Wellness's personal care\nand wellness portfolio.\n\n\"This relationship gives Vector early exposure to a company working in an area\nadjacent to our own. Women's health and the use of peptides are important\nareas of innovation, and our proposed exclusive arrangement with Whoopi\nWellness will help build awareness of Vector's approach to the best quality\nand safety,\" said Bill Jackson, Chief Executive Officer of Vector Science and\nTherapeutics. \"We look forward to helping bring Whoopi Wellness products to\nmarket and supporting the company's mission to improve women's wellness.\"\n\n\"Taking care of ourselves and the people we love is at the heart of Whoopi\nWellness,\" said Whoopi Goldberg, Co-Founder. \"We're creating products for real\npeople and real lives, with quality, care and trust behind everything we do.\nWorking with Vector brings science and innovation into that vision, and I'm\nexcited about what we can create together.\"\n\n\"Our customers trust us to be thoughtful about what goes into every product we\nmake,\" said Davina Kaonohi, Co-Founder, Whoopi Wellness. \"Vector's commitment\nto rigorous testing and manufacturing quality made them the right partner as\nwe explore peptide-based products for women's wellness. This investment\nreflects shared confidence in where we're headed together.\"\n\nAbout Vector Science and Therapeutics Corp.\n\nVector Science and Therapeutics Corp. (TSXV: PAIN) is a medical technology\ncompany advancing drug delivery technology and pharma-grade peptide\nmanufacturing for the sports medicine, regenerative medicine, and pain\nmanagement markets. Vector's peptides are pharma-grade, not research-grade:\nthey are manufactured under cGMP, FDA, and ISO-compliant conditions,\nRx-labeled, and sold directly to physicians for physician use, rather than\ndistributed through the research-only channels associated with research-grade\nmaterial. The Company's product and intellectual property portfolio is focused\non advanced transdermal delivery, precision catheter systems, localized pain\nmanagement, pancreatic oncology, and smart wound care. Vector is headquartered\nin Mequon, Wisconsin. For more information, visit https://vectorscience.co/\n(https://vectorscience.co/) .\n\nAbout Whoopi Wellness, Inc.\n\nWhoopi Wellness, Inc. is a consumer health and lifestyle company, a subsidiary\nof WhoopFam LLC and co-founded by Whoopi Goldberg, bringing her voice,\ncultural relevance and lifelong commitment to well-being into a growing\nportfolio of intimate care, personal care, beauty and wellness products. Built\non a legacy of care, comfort and wisdom, the company is creating thoughtful,\nhigh-quality products designed to support real bodies and real lives at every\nstage. With a vision that spans generations, Whoopi Wellness is building a\ntrusted platform rooted in honesty, inclusivity and care.\n\n Cautionary Note Regarding Forward-Looking Information\n\nThis news release contains \"forward-looking information\" within the meaning of\napplicable Canadian securities legislation. Forward-looking information\nincludes, but is not limited to, statements regarding the proposed exclusive\narrangement between the parties, the development and commercialization of\npeptide-based products, and the anticipated benefits of the relationship\ndescribed in this release. Forward-looking information is based on\nmanagement's current expectations and assumptions and is subject to known and\nunknown risks, uncertainties, and other factors that may cause actual results\nto differ materially from those expressed or implied, including the risk that\nthe parties do not finalize a definitive exclusive arrangement, that the SAFE\ndoes not convert into equity, or that anticipated products are not\nsuccessfully developed or commercialized. Readers are cautioned not to place\nundue reliance on forward-looking information. The Company does not undertake\nany obligation to update forward-looking information except as required by\napplicable securities laws.\n\nNeither the TSX Venture Exchange nor its Regulation Services Provider (as that\nterm is defined in the policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this news release.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/vector-science-and-therapeutics-corp-announces-collaboration-and-safe-investment-in-whoopi-wellness-inc-302906467.html\n(https://www.prnewswire.com/news-releases/vector-science-and-therapeutics-corp-announces-collaboration-and-safe-investment-in-whoopi-wellness-inc-302906467.html)\n\nSOURCE Vector Sciences & Therapeutics\n\n\n\nVector Science and Therapeutics Corp., investor@vectorscience.co, www.vectorscience.co; Whoopi Wellness, Inc., |  Davina Kaonohi, Co-Founder, davina@whoopiwellness.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1731895/Vector-Sciences-Therapeutics-Logo.jpg?id=OA3013256\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnb2dml4a-20261013","title":"Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.","author":"PR Newswire","ticker":"PAIN","created":"2026-10-13T11:30:00.089Z","tickers":["PAIN"],"exchange":"","article_body":"Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.\nPR Newswire\n\nMEQUON, Wis., Oct. 13, 2026\n\nInvestment advances collaboration on peptide-based products for women's\nwellness\n\nMEQUON, Wis., Oct. 13, 2026 /PRNewswire/ -- Vector Science and Therapeutics\nCorp. (TSXV: PAIN) (\"Vector\" or the \"Company\") today announced that it has\nentered into a strategic relationship with Whoopi Wellness, Inc. (\"Whoopi\nWellness\"), a subsidiary of WhoopFam LLC and co-founded by Whoopi Goldberg.\n\nVector has made an investment in Whoopi Wellness through a Simple Agreement\nfor Future Equity (SAFE). The companies plan to work together on peptide-based\nproducts for women's wellness using peptides formulated and manufactured by\nVector. Vector only uses peptides that have been tested using validated\nanalytical testing to ensure purity, potency, endotoxin levels and sterility.\nWhoopi Wellness is committed to high-quality, safe, rigorously tested peptides\nin its products.\n\nStrategic Rationale\n\nVector believes this relationship brings together Vector's peptide\nmanufacturing expertise and Whoopi Wellness's consumer brand to develop\nproducts for women's wellness.\n\nVector's proprietary delivery technology is central to the relationship. The\nCompany's intellectual property portfolio includes 15 pending patent\napplications covering multi-route peptide and biologic delivery, lyophilized\npeptide formulations with point-of-care reconstitution, and advanced\ntransdermal delivery. Peptides are typically unstable once in liquid form,\nwhich has limited how they can be used in consumer products. Vector's\nexpertise is in the novel delivery of molecules in multiple forms while\npreserving the integrity of the molecule. In the Whoopi Wellness products,\nVector will be using its IP and formulation knowledge to deliver products with\npeptides that retain their potency and that are shelf stable in liquid and gel\nformats. Vector believes this capability positions the companies to explore\npeptide-based products in formats suited to Whoopi Wellness's personal care\nand wellness portfolio.\n\n\"This relationship gives Vector early exposure to a company working in an area\nadjacent to our own. Women's health and the use of peptides are important\nareas of innovation, and our proposed exclusive arrangement with Whoopi\nWellness will help build awareness of Vector's approach to the best quality\nand safety,\" said Bill Jackson, Chief Executive Officer of Vector Science and\nTherapeutics. \"We look forward to helping bring Whoopi Wellness products to\nmarket and supporting the company's mission to improve women's wellness.\"\n\n\"Taking care of ourselves and the people we love is at the heart of Whoopi\nWellness,\" said Whoopi Goldberg, Co-Founder. \"We're creating products for real\npeople and real lives, with quality, care and trust behind everything we do.\nWorking with Vector brings science and innovation into that vision, and I'm\nexcited about what we can create together.\"\n\n\"Our customers trust us to be thoughtful about what goes into every product we\nmake,\" said Davina Kaonohi, Co-Founder, Whoopi Wellness. \"Vector's commitment\nto rigorous testing and manufacturing quality made them the right partner as\nwe explore peptide-based products for women's wellness. This investment\nreflects shared confidence in where we're headed together.\"\n\nAbout Vector Science and Therapeutics Corp.\n\nVector Science and Therapeutics Corp. (TSXV: PAIN) is a medical technology\ncompany advancing drug delivery technology and pharma-grade peptide\nmanufacturing for the sports medicine, regenerative medicine, and pain\nmanagement markets. Vector's peptides are pharma-grade, not research-grade:\nthey are manufactured under cGMP, FDA, and ISO-compliant conditions,\nRx-labeled, and sold directly to physicians for physician use, rather than\ndistributed through the research-only channels associated with research-grade\nmaterial. The Company's product and intellectual property portfolio is focused\non advanced transdermal delivery, precision catheter systems, localized pain\nmanagement, pancreatic oncology, and smart wound care. Vector is headquartered\nin Mequon, Wisconsin. For more information, visit https://vectorscience.co/\n(https://vectorscience.co/) .\n\nAbout Whoopi Wellness, Inc.\n\nWhoopi Wellness, Inc. is a consumer health and lifestyle company, a subsidiary\nof WhoopFam LLC and co-founded by Whoopi Goldberg, bringing her voice,\ncultural relevance and lifelong commitment to well-being into a growing\nportfolio of intimate care, personal care, beauty and wellness products. Built\non a legacy of care, comfort and wisdom, the company is creating thoughtful,\nhigh-quality products designed to support real bodies and real lives at every\nstage. With a vision that spans generations, Whoopi Wellness is building a\ntrusted platform rooted in honesty, inclusivity and care.\n\n Cautionary Note Regarding Forward-Looking Information\n\nThis news release contains \"forward-looking information\" within the meaning of\napplicable Canadian securities legislation. Forward-looking information\nincludes, but is not limited to, statements regarding the proposed exclusive\narrangement between the parties, the development and commercialization of\npeptide-based products, and the anticipated benefits of the relationship\ndescribed in this release. Forward-looking information is based on\nmanagement's current expectations and assumptions and is subject to known and\nunknown risks, uncertainties, and other factors that may cause actual results\nto differ materially from those expressed or implied, including the risk that\nthe parties do not finalize a definitive exclusive arrangement, that the SAFE\ndoes not convert into equity, or that anticipated products are not\nsuccessfully developed or commercialized. Readers are cautioned not to place\nundue reliance on forward-looking information. The Company does not undertake\nany obligation to update forward-looking information except as required by\napplicable securities laws.\n\nNeither the TSX Venture Exchange nor its Regulation Services Provider (as that\nterm is defined in the policies of the TSX Venture Exchange) accepts\nresponsibility for the adequacy or accuracy of this news release.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/vector-science-and-therapeutics-corp-announces-collaboration-and-safe-investment-in-whoopi-wellness-inc-302906467.html\n(https://www.prnewswire.com/news-releases/vector-science-and-therapeutics-corp-announces-collaboration-and-safe-investment-in-whoopi-wellness-inc-302906467.html)\n\nSOURCE Vector Sciences & Therapeutics\n\n\n\nVector Science and Therapeutics Corp., investor@vectorscience.co, www.vectorscience.co; Whoopi Wellness, Inc., |  Davina Kaonohi, Co-Founder, davina@whoopiwellness.com\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1731895/Vector-Sciences-Therapeutics-Logo.jpg?id=OA3013256\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-10-13T11:30:00.138314609Z","server_sent_at_ms":1791891000138},"received_at":"2026-10-13T11:30:00.190Z","source_url":"https://www.prnewswire.com/news-releases/vector-science-and-therapeutics-corp-announces-collaboration-and-safe-investment-in-whoopi-wellness-inc-302906467.html"},"analysis":{"id":"155642","press_release_id":"167328","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":["SAFE investment amount not disclosed","proposed exclusive arrangement not yet definitive; SAFE may not convert into equity","products remain exploratory with no committed commercialization timeline"],"eventType":"partnership","narrative":"Vector Science and Therapeutics (TSXV: PAIN) announced a strategic relationship with Whoopi Wellness, including an investment via a SAFE; the dollar amount was not disclosed.\n\nThe companies plan to co-develop peptide-based products for women's wellness using Vector's cGMP peptide manufacturing and its 15 pending patent applications covering multi-route and transdermal peptide delivery.\n\nThe deal gives Vector early consumer-brand exposure, though the arrangement is non-binding until a definitive exclusive agreement is finalized and products are far from commercialization.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Micro-cap medical tech ties up with Whoopi Goldberg-backed consumer brand, but undisclosed investment size and non-definitive terms temper the headline."},"keyFigures":{"customDimensions":{"pending_patent_applications":15}},"quotedText":"This relationship gives Vector early exposure to a company working in an area adjacent to our own.","namedEntities":{"people":[{"name":"Bill Jackson","role":"CEO of Vector Science and Therapeutics"},{"name":"Whoopi Goldberg","role":"Co-Founder of Whoopi Wellness"},{"name":"Davina Kaonohi","role":"Co-Founder of Whoopi Wellness"}],"products":["SAFE (Simple Agreement for Future Equity)","peptide-based women's wellness products"],"companies":[{"name":"Vector Science and Therapeutics Corp.","ticker":"PAIN","relationship":"filer/investor"},{"name":"Whoopi Wellness, Inc.","relationship":"partner/investment target"},{"name":"WhoopFam LLC","relationship":"parent of Whoopi Wellness"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"A strategic collaboration plus an undisclosed-size SAFE investment with a celebrity-backed consumer brand. No financial terms disclosed and products are early-stage/exploratory; meaningful but not yet market-moving."},"tickerRelevance":{"others":[],"primary":"PAIN"},"globalImportance":18,"audienceRelevance":25,"eventTypeSecondary":["other"],"importanceComponents":{"tickerTier":"micro-cap TSXV","eventGravity":"partnership-plus-SAFE, terms undisclosed","definitiveness":"non-binding, exploratory","householdBrandBoost":"Whoopi Goldberg co-founder adds name recognition"}},"event_type":"partnership","event_type_secondary":["other"],"sentiment":"bullish","material_impact_score":2,"narrative":"Vector Science and Therapeutics (TSXV: PAIN) announced a strategic relationship with Whoopi Wellness, including an investment via a SAFE; the dollar amount was not disclosed.\n\nThe companies plan to co-develop peptide-based products for women's wellness using Vector's cGMP peptide manufacturing and its 15 pending patent applications covering multi-route and transdermal peptide delivery.\n\nThe deal gives Vector early consumer-brand exposure, though the arrangement is non-binding until a definitive exclusive agreement is finalized and products are far from commercialization.","key_figures":{"customDimensions":{"pending_patent_applications":15}},"named_entities":{"people":[{"name":"Bill Jackson","role":"CEO of Vector Science and Therapeutics"},{"name":"Whoopi Goldberg","role":"Co-Founder of Whoopi Wellness"},{"name":"Davina Kaonohi","role":"Co-Founder of Whoopi Wellness"}],"products":["SAFE (Simple Agreement for Future Equity)","peptide-based women's wellness products"],"companies":[{"name":"Vector Science and Therapeutics Corp.","ticker":"PAIN","relationship":"filer/investor"},{"name":"Whoopi Wellness, Inc.","relationship":"partner/investment target"},{"name":"WhoopFam LLC","relationship":"parent of Whoopi Wellness"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-13T11:30:05.904Z","global_importance":18,"audience_relevance":25,"importance_components":{"tickerTier":"micro-cap TSXV","eventGravity":"partnership-plus-SAFE, terms undisclosed","definitiveness":"non-binding, exploratory","householdBrandBoost":"Whoopi Goldberg co-founder adds name recognition"}},"durationMs":5702,"modelName":"glm-5.3-flashx"}}